Home Products Most Popular Contact
No items in your cart.
The page below is a sample from the LabCE course Rh-Negative Female with Anti-D at Delivery: A Case Study (retired 6/11/2018). Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Rh-Negative Female with Anti-D at Delivery: A Case Study (retired 6/11/2018) (online CE course) »
How to Subscribe
Individual course$20 Add to cart

Related Uses

RhIg is also indicated in these special circumstances:

  • Antepartum fetal maternal hemorrhage (FMH), suspected or proven as a result of placenta previa, amniocentesis, chorionic villus sampling, cordocentesis, other obstetrical manipulative procedures (e.g., external version or abdominal trauma such as may occur in a car accident or fall);
  • Therapeutic abortion;
  • Vaginal bleeding during pregnancy;
  • Loss or threatened loss of fetus at any gestational stage;
  • Ectopic pregnancy.

For these non-routine indications, depending on the level of medical care the pregnant woman receives or the awareness level of the risks involved, there is increased potential for RhIg to be administered inappropriately or not at all.